Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. - Wikidata - wikimedia - TriplyDB

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.

http://www.wikidata.org/entity/Q39134108

about

The Sin3a repressor complex is a master regulator of STAT transcriptional activity Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na The use of neuroproteomics in drug abuse research Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics Pdx1 is post-translationally modified in vivo and serine 61 is the principal site of phosphorylation µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume Ultrafast immunoassays by coupling dielectrophoretic biomarker enrichment in nanoslit channel with electrochemical detection on graphene.Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.Nanoimmunoassay to Detect Responses in Head and Neck Cancer: Feasibility in a Mouse Model.Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes.Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.Automated microfluidic protein immunoblotting.PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.Chronic myeloid leukemia: mechanisms of blastic transformation Alteration of the lipid profile in lymphomas induced by MYC overexpression.Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling Clinical proteomics of myeloid leukemia.Interplay of DNA damage and cell cycle signaling at the level of human replication protein A Molecular systems pharmacology: isoelectric focusing signature of protein kinase Cδ provides an integrated measure of its modulation in response to ligands Microfluidic Western blotting of low-molecular-mass proteins Microfluidic Western blotting.A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.Sensitive targeted quantification of ERK phosphorylation dynamics and stoichiometry in human cells without affinity enrichment.Active ERK2 is sufficient to mediate growth arrest and differentiation signaling Defining the role of TORC1/2 in multiple myeloma.Capillary Isoelectric Focusing Immunoassay for Fat Cell Differentiation Proteomics.Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1 "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.Microfluidic integration for automated targeted proteomic assays Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activation Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.Capillary Isoelectric Focusing of Akt Isoforms Identifies Highly Dynamic Phosphorylation in Neuronal Cells and Brain Tissue BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancer Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.Disruptive by design: a perspective on engineering in analytical chemistry.

P2860

Q24292983-A118A031-27E8-47CD-9DC9-B61A649BAD2A Q24597616-61E821EE-A896-409E-B17C-F0726A2B0CE3 Q27010380-9085AF74-8F67-4E7D-9D27-33D875713534 Q28396457-33D2EF6D-BDDD-46A4-B38D-21577FF6FDD3 Q28730649-C3D519AF-5327-466A-BC70-F70F08EC1A5A Q28749053-13D2177B-03DD-4491-B356-BAFCB74B7735 Q30278475-18A23109-5270-4678-AF17-4BF4E1536363 Q30402943-B1651D38-8A43-449E-B656-32C252FB8689 Q30457748-071545DB-B084-470E-AEF1-AC61F466ABF4 Q30593372-668A160C-038D-42BF-B5CB-65B225E2C063 Q33610394-A42C8E28-DBF3-41B6-987C-9B20479BCF3F Q33732615-C3647428-94F3-4E55-B77C-9FC4D21D3152 Q33805920-C3B6A8F0-4584-4E18-9A67-99B0872AF991 Q33968037-62359FF8-4E6D-4923-9FBD-A2DEFB321020 Q33971890-B4364D4E-65C6-4988-A83F-5155ED4F147F Q33991646-9DC98980-F5C8-4C4D-BABE-0686DCC6EE5B Q33999524-961ABAF2-B981-4F49-9648-79F64F3F85BE Q34007468-A97C2E78-097E-4F55-AFBF-2873F1EDF0A1 Q34435702-295D7D79-EF31-4C2E-AD9C-4DC35E6763B6 Q34464315-B737277E-367E-46F7-922C-3903FBD67A23 Q34504270-FA950038-3065-4858-B909-DE7C00267B86 Q35186717-B05D1364-2642-4C38-8513-BE7FEAA779DF Q35193821-F6DE16D4-34E8-4057-B560-7008A8A32E35 Q35202386-AC79BD95-8DD5-458D-AF23-622CBA516D14 Q35631315-5F0E8A58-88FC-4BED-87B0-0B62F55A4F57 Q35679898-60A67A3C-94EB-40A2-939C-2D127B74652A Q35743835-67CCC58D-9BFC-4651-BE3A-F72090BBE129 Q35799776-0C73736C-B299-4DE0-B8DA-59C41689EB9F Q35924982-F1CCF8EA-08F3-4521-8846-58897A4A79A5 Q36155061-C0893E0B-59A3-4990-A980-04C8C58CDB8B Q36443572-B6038DCB-288C-481F-BB3A-8AE531B9A623 Q36507980-A4D97E4F-52F3-4695-89D1-B682942C77F9 Q36544893-3246A559-86F9-422E-A3BD-FC32B35D5208 Q36547383-A69FD570-A563-44FB-8DFE-753239056ECD Q36876219-C860DDF0-D138-4047-9B4F-9B1F7D012ABE Q37235693-910ACF67-E5B8-4B5E-B1FE-6A512072172C Q37247510-9C620EFD-ADCE-4658-8B52-E7FE70CCE7FB Q37297137-1B63D024-0938-4703-B53B-748BFA900B90 Q37351122-295CC067-3D25-4B8A-8BB1-37CC90227C8C Q37373441-9C0EAC52-95CE-4C05-BDCF-CC2AA8F10269

P2860

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.

http://www.wikidata.org/entity/Q39134108

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@en

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@nl

type

label

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@en

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@nl

prefLabel

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@en

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@nl

P1433

Q39134108-F529A525-1854-4130-92C5-982C31761934

P1476

Q39134108-A9A5EB96-88E0-42DC-AED9-FA7C2ECF5EB0

P2093

Q39134108-0E988EF8-EC9F-4534-951E-9F6031B0E676

Q39134108-1280F900-F2E1-40F3-88F1-2F5B34A86381

Q39134108-160492C2-ED19-4006-A23F-B88927B04C2C

Q39134108-3A49E908-5C53-4754-A77C-668D2FC9CFED

Q39134108-3E1EC834-7327-41E8-A87E-F11D27366DD2

Q39134108-43EC333A-3F4F-4A02-98C4-AEF8D30F450F

Q39134108-7FB91DFC-277F-4482-85D0-0D54895594A0

Q39134108-845F7908-F5B4-4D05-AECF-46B0D4F2725B

Q39134108-84AE73CB-F92B-4281-8DC6-F2D680397D1B

Q39134108-85749D1B-1F93-4F8D-8D5A-78225ACE7585

P2860

Q39134108-05FF4DAA-ABA2-45AC-AD2D-9D6D9AC4043A

Q39134108-06025056-3E3F-429C-A523-646DBDC94DA4

Q39134108-163A5DAA-4C10-409B-94F5-10630DCEEE11

Q39134108-208793CA-A61F-46A3-B780-936EE5C65936

Q39134108-23F505DA-CC0D-4358-949F-FAAB8D1B8717

Q39134108-273311D9-FB97-4789-81DD-E9C3AF715823

Q39134108-376B2041-A0AC-448A-88C7-365BC667A699

Q39134108-3A728CBE-654E-44DC-AFBD-9B767AFF786E

Q39134108-50291BD8-3CBE-4975-86D8-10576777BD1A

Q39134108-532F8F6C-EBDE-4550-A4F3-31F38366B0B5

P2888

Q39134108-6192A3C2-6722-4282-B707-0C21621740F5

P304

Q39134108-DBB43BDA-5BF4-4BFE-99FB-833837B26A98

P31

Q39134108-F27A57B7-6BF3-42D6-904A-87A4ED8718AB

P356

Q39134108-10EE4645-FCCE-45CA-AAEE-2B901DE0953F

P407

Q39134108-48065EE0-6022-430C-ABAB-A991624326B0

P433

Q39134108-BF922201-47FE-4631-9962-A19415F5DC96

P478

Q39134108-9917A8BA-E0C4-42A9-90B8-8A87179144E9

P577

Q39134108-6E25D06B-B2DC-4CB6-A906-1F51782F9F49

P6179

Q39134108-661F0B23-1E7C-4D40-AAD7-DA8B5AEDC886

P698

Q39134108-865C1C7E-1354-4080-93DF-6565A1D6672E

P932

Q39134108-060ABFB8-F399-4334-AFAD-9AF33CD2F74A

P356

P1433

Nature Medicine

P1476

Nanofluidic proteomic assay fo ...... ivation in clinical specimens.

@en

P2093

Ada X Yee

http://www.w3.org/2001/XMLSchema#string

Alice C Fan

http://www.w3.org/2001/XMLSchema#string

Amy E Shirer

http://www.w3.org/2001/XMLSchema#string

Daryl Taketa

http://www.w3.org/2001/XMLSchema#string

David W Voehringer

http://www.w3.org/2001/XMLSchema#string

Dean W Felsher

http://www.w3.org/2001/XMLSchema#string

Debabrita Deb-Basu

http://www.w3.org/2001/XMLSchema#string

Jason R Gotlib

http://www.w3.org/2001/XMLSchema#string

Liwen Xu

http://www.w3.org/2001/XMLSchema#string

Mathias W Orban

http://www.w3.org/2001/XMLSchema#string

P2860

Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

The great MYC escape in tumorigenesis

Cancer genes and the pathways they control

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

BRAF mutation predicts sensitivity to MEK inhibition

Cancer and genomics.

Sensing and integration of Erk and PI3K signals by Myc

Growth factor independence and BCR/ABL transformation: promise and pitfalls of murine model systems and assays.

P2888

P304

566-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.1903

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1011369855

http://www.w3.org/2001/XMLSchema#string

P698

19363496

http://www.w3.org/2001/XMLSchema#string

P932

4006986

http://www.w3.org/2001/XMLSchema#string